These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 2868653)
1. Sulfasalazine and new analogues. Friedman G Am J Gastroenterol; 1986 Feb; 81(2):141-4. PubMed ID: 2868653 [No Abstract] [Full Text] [Related]
2. Topical salicylate therapy (4-ASA and 5-ASA enemas). Ginsberg AL Gastroenterol Clin North Am; 1989 Mar; 18(1):35-42. PubMed ID: 2563990 [TBL] [Abstract][Full Text] [Related]
3. Will there be a next generation of sulfasalazine? Goldman P Gastroenterology; 1982 Nov; 83(5):1138-41. PubMed ID: 6126420 [No Abstract] [Full Text] [Related]
4. [Treatment of chronic inflammatory intestinal diseases with 5-aminosalicylic acid]. Malchow H Internist (Berl); 1987 Jan; 28(1):14-20. PubMed ID: 2883152 [No Abstract] [Full Text] [Related]
5. [Inhibition of intestinal leukotriene formation as a possible mechanism of action of sulfasalazine, 5-aminosalicylic acid and 4-aminosalicylic acid]. Peskar BM Klin Wochenschr; 1988 Nov; 66(22):1147-50. PubMed ID: 2907066 [No Abstract] [Full Text] [Related]
6. Sulphasalazine in inflammatory bowel disease: recent advances. Cooper BT N Z Med J; 1986 Oct; 99(811):757-9. PubMed ID: 2877428 [No Abstract] [Full Text] [Related]
7. [New developments in the treatment of inflammatory bowel diseases. What is certain?]. Feurle GE Z Gastroenterol Verh; 1990 Apr; 25():150-2. PubMed ID: 1694355 [No Abstract] [Full Text] [Related]
8. [Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid]. Feurle GE; Helmstädter V Dtsch Med Wochenschr; 1986 May; 111(18):721-2. PubMed ID: 2870908 [No Abstract] [Full Text] [Related]
9. Therapeutic efficacy of sulfasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease. Klotz U; Maier K; Fischer C; Heinkel K N Engl J Med; 1980 Dec; 303(26):1499-502. PubMed ID: 6107853 [TBL] [Abstract][Full Text] [Related]
10. 5-Aminosalicylic acid for the treatment of inflammatory bowel disease. Dew MJ; Evans BK; Rhodes J Gastroenterology; 1984 Aug; 87(2):480-1. PubMed ID: 6735091 [No Abstract] [Full Text] [Related]
11. [Salazosulfapyridine or 5-aminosalicylic acid]. van Hees PA Ned Tijdschr Geneeskd; 1987 May; 131(22):931-4. PubMed ID: 2885762 [No Abstract] [Full Text] [Related]
12. Sulfasalazine and 5-ASA compounds. Allgayer H Gastroenterol Clin North Am; 1992 Sep; 21(3):643-58. PubMed ID: 1355468 [TBL] [Abstract][Full Text] [Related]
13. Sulfasalazine and new analogues in inflammatory bowel disease, with focus on Crohn's disease. van Hees PA Acta Gastroenterol Belg; 1987; 50(5):555-9. PubMed ID: 2902723 [No Abstract] [Full Text] [Related]
14. [5-Aminosalicylic acid--a new therapeutic possibility in chronic inflammatory bowel disease]. Hartmann F Leber Magen Darm; 1986 Jan; 16(1):20-7. PubMed ID: 3515082 [No Abstract] [Full Text] [Related]
15. [Prevention of recurrence of chronic inflammatory bowel diseases]. Dölle W; Hartmann F Verh Dtsch Ges Inn Med; 1989; 95():322-6. PubMed ID: 2574922 [No Abstract] [Full Text] [Related]
16. Salazopyrin and its newer analogues in the treatment of inflammatory bowel disease. Banatwala N J Pak Med Assoc; 1985 Mar; 35(3):64-8. PubMed ID: 2860256 [No Abstract] [Full Text] [Related]
17. Oral mesalamine for ulcerative colitis. Med Lett Drugs Ther; 1992 Aug; 34(877):80-1. PubMed ID: 1353858 [No Abstract] [Full Text] [Related]